-
Je něco špatně v tomto záznamu ?
Intramural Venous Ethanol Infusion for Refractory Ventricular Arrhythmias: Outcomes of a Multicenter Experience
L. Tavares, A. Lador, S. Fuentes, A. Da-Wariboko, K. Blaszyk, K. Malaczynska-Rajpold, G. Papiashvili, S. Korolev, P. Peichl, J. Kautzner, M. Webber, D. Hooks, M. Rodríguez-Mañero, D. Di Toro, C. Labadet, T. Sasaki, K. Okishige, A. Patel, PA....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, multicentrická studie, Research Support, N.I.H., Extramural, práce podpořená grantem
- MeSH
- ethanol * MeSH
- komorová tachykardie * farmakoterapie MeSH
- lidé středního věku MeSH
- lidé MeSH
- perikard MeSH
- srdeční arytmie MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
OBJECTIVES: The aim of this study was to assess the long-term efficacy and outcomes of retrograde venous ethanol ablation in treating ventricular arrhythmias (VAs). BACKGROUND: Retrograde coronary venous ethanol ablation (RCVEA) can be effective for radiofrequency ablation (RFA)-refractory VAs, particularly those arising in the LV summit (LVS). METHODS: Patients with drug and RFA-refractory VAs were considered for RCVEA after RF failure attempts. Intramural coronary veins (tributaries of the great cardiac, anterior interventricular, lateral cardiac, posterolateral, and middle cardiac) were mapped using an angioplasty wire. Ethanol infusion was delivered in veins with appropriate signals. RESULTS: Of 63 patients (age 63 ± 14 years; 60% men) with VAs (71% extrasystole, 29% ventricular tachycardia, 76% LVS origin), RCVEA was performed in 56 patients who had suitable vein branches. These were defined as those amenable to cannulation and with intramural signals that preceded those mapped in the epicardium or endocardium and had better matching pace maps or entrainment responses. Seven patients had no suitable veins and underwent RFA. In 38 of 56 (68%) patients, the VAs were successfully terminated exclusively with ethanol infusion. In 17 of 56 (30%) patients, successful ablation was achieved using ethanol with adjunctive RFA in the vicinity of the infused vein due to acute recurrence or ethanol-induced change in VA morphology. Overall, isolated or adjuvant RCVEA was successful in 55 of 56 (98%) patients. At 1-year follow-up, 77% of patients were free of recurrent arrhythmias. Procedural complications included 2 venous dissections that led to pericardial effusions. CONCLUSIONS: RCVEA offers a significant long-term effective treatment for patients with drug and RF-refractory VAs.
Arrhythmia Unit Complexo Hospitalario de Santiago de Compostela A Coruña Spain
Arrhythmia Unit Jo Ann Medical Center Tbilisi Georgia USA
Federal Research and Clinical Center of the FMBA of Russia Moscow Russia
Heart Center Japan Red Cross Yokohama City Bay Hospital Yokohama Japan
Heart Rhythm Center National Hospital Organization Disaster Medical Center Tokyo Japan
Hospital CEMIC Buenos Aires Argentina
Institute for Clinical and Experimental Medicine Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026474
- 003
- CZ-PrNML
- 005
- 20211026132900.0
- 007
- ta
- 008
- 211013s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jacep.2020.07.023 $2 doi
- 035 __
- $a (PubMed)33121671
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Tavares, Liliana $u Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA
- 245 10
- $a Intramural Venous Ethanol Infusion for Refractory Ventricular Arrhythmias: Outcomes of a Multicenter Experience / $c L. Tavares, A. Lador, S. Fuentes, A. Da-Wariboko, K. Blaszyk, K. Malaczynska-Rajpold, G. Papiashvili, S. Korolev, P. Peichl, J. Kautzner, M. Webber, D. Hooks, M. Rodríguez-Mañero, D. Di Toro, C. Labadet, T. Sasaki, K. Okishige, A. Patel, PA. Schurmann, AS. Dave, TG. Rami, M. Valderrábano
- 520 9_
- $a OBJECTIVES: The aim of this study was to assess the long-term efficacy and outcomes of retrograde venous ethanol ablation in treating ventricular arrhythmias (VAs). BACKGROUND: Retrograde coronary venous ethanol ablation (RCVEA) can be effective for radiofrequency ablation (RFA)-refractory VAs, particularly those arising in the LV summit (LVS). METHODS: Patients with drug and RFA-refractory VAs were considered for RCVEA after RF failure attempts. Intramural coronary veins (tributaries of the great cardiac, anterior interventricular, lateral cardiac, posterolateral, and middle cardiac) were mapped using an angioplasty wire. Ethanol infusion was delivered in veins with appropriate signals. RESULTS: Of 63 patients (age 63 ± 14 years; 60% men) with VAs (71% extrasystole, 29% ventricular tachycardia, 76% LVS origin), RCVEA was performed in 56 patients who had suitable vein branches. These were defined as those amenable to cannulation and with intramural signals that preceded those mapped in the epicardium or endocardium and had better matching pace maps or entrainment responses. Seven patients had no suitable veins and underwent RFA. In 38 of 56 (68%) patients, the VAs were successfully terminated exclusively with ethanol infusion. In 17 of 56 (30%) patients, successful ablation was achieved using ethanol with adjunctive RFA in the vicinity of the infused vein due to acute recurrence or ethanol-induced change in VA morphology. Overall, isolated or adjuvant RCVEA was successful in 55 of 56 (98%) patients. At 1-year follow-up, 77% of patients were free of recurrent arrhythmias. Procedural complications included 2 venous dissections that led to pericardial effusions. CONCLUSIONS: RCVEA offers a significant long-term effective treatment for patients with drug and RF-refractory VAs.
- 650 _2
- $a srdeční arytmie $7 D001145
- 650 12
- $a ethanol $7 D000431
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a perikard $7 D010496
- 650 12
- $a komorová tachykardie $x farmakoterapie $7 D017180
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Lador, Adi $u Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA
- 700 1_
- $a Fuentes, Stephanie $u Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA
- 700 1_
- $a Da-Wariboko, Akanibo $u Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA
- 700 1_
- $a Blaszyk, Krzysztof $u Poznan University of Medical Sciences, Poznan, Poland
- 700 1_
- $a Malaczynska-Rajpold, Katarzyna $u Poznan University of Medical Sciences, Poznan, Poland
- 700 1_
- $a Papiashvili, Giorgi $u Arrhythmia Unit, Jo Ann Medical Center, Tbilisi, Georgia, USA
- 700 1_
- $a Korolev, Sergey $u Federal Research and Clinical Center of the FMBA of Russia, Moscow, Russia
- 700 1_
- $a Peichl, Petr $u Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
- 700 1_
- $a Kautzner, Josef $u Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
- 700 1_
- $a Webber, Matthew $u Wellington Hospital, Wellington, New Zealand
- 700 1_
- $a Hooks, Darren $u Wellington Hospital, Wellington, New Zealand
- 700 1_
- $a Rodríguez-Mañero, Moisés $u Arrhythmia Unit, Complexo Hospitalario de Santiago de Compostela, A Coruña, Spain
- 700 1_
- $a Di Toro, Darío $u Hospital CEMIC, Buenos Aires, Argentina
- 700 1_
- $a Labadet, Carlos $u Hospital CEMIC, Buenos Aires, Argentina
- 700 1_
- $a Sasaki, Takeshi $u Heart Rhythm Center, National Hospital Organization Disaster Medical Center, Tokyo, Japan
- 700 1_
- $a Okishige, Kaoru $u Heart Center, Japan Red Cross Yokohama City Bay Hospital, Yokohama, Japan
- 700 1_
- $a Patel, Apoor $u Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA
- 700 1_
- $a Schurmann, Paul A $u Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA
- 700 1_
- $a Dave, Amish S $u Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA
- 700 1_
- $a Rami, Tapan G $u Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA
- 700 1_
- $a Valderrábano, Miguel $u Division of Cardiac Electrophysiology, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas, USA. Electronic address: mvalderrabano@houstonmethodist.org
- 773 0_
- $w MED00193518 $t JACC. Clinical electrophysiology $x 2405-5018 $g Roč. 6, č. 11 (2020), s. 1420-1431
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33121671 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026132906 $b ABA008
- 999 __
- $a ok $b bmc $g 1715253 $s 1146981
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 6 $c 11 $d 1420-1431 $e 20200930 $i 2405-5018 $m JACC. Clinical electrophysiology $n JACC Clin Electrophysiol $x MED00193518
- LZP __
- $a Pubmed-20211013
